Evan Castiglia

Evan Castiglia

Venture Investments

Current role

Evan is an Investment principal at Philips Ventures based in Amsterdam, and currently serves as a Director of Carevive and Siilo. He’s also a member of the investment council for imec.xpand’s hardware-based nanotechnology fund. 


Prior to joining Philips Ventures, Evan was the Chief Business Officer of RareCyte, a venture-backed life science company based in Seattle, Washington. Evan holds an MBA from the University of Oxford — where he was an OUI-SBS Fellow and graduated with distinction — and a bachelor’s degree from Gonzaga University.

Areas of focus


  • Software-enabled care delivery
  • Digital therapeutics
  • Intelligent automation
  • Data and interoperability
  • In-silico clinical models and tools

Want to become a start-up partner with Philips Ventures?

Changing healthcare

Together, we’re changing healthcare

Together, we’re changing healthcare

Philips Ventures champions innovative start-ups with breakthrough solutions.

使用最新版 Microsoft Edge、Google Chrome 或 Firefox 瀏覽本網站效果最佳。